Investigating	O
Synthetic	O
Oligonucleotide	B:C0028953
Targeting	O
of	O
Mir31	O
in	O
Duchenne	O
Muscular	I:C0013264
Dystrophy	I:C0013264
.	O

Investigating	O
Synthetic	O
Oligonucleotide	O
Targeting	O
of	O
Mir31	B:C2607480
in	O
Duchenne	O
Muscular	I:C0013264
Dystrophy	I:C0013264
.	O

Investigating	O
Synthetic	O
Oligonucleotide	O
Targeting	O
of	O
Mir31	O
in	O
Duchenne	B:C0013264
Muscular	I:C0013264
Dystrophy	I:C0013264
.	O

Exon	B:C0035687
-skipping	I:C0035687
via	O
synthetic	O
antisense	O
oligonucleotides	I:C0079925
represents	O
one	O
of	O
the	O
most	O
promising	O
potential	O
therapies	O
for	O
Duchenne	O
muscular	I:C0013264
dystrophy	I:C0013264
(	O
Duchenne	O
muscular	I:C0013264
dystrophy	I:C0013264
)	O
,	O
yet	O
this	O
approach	O
is	O
highly	O
sequence	O
-	I:C1624609
specific	I:C1624609
and	O
thus	O
each	O
oligonucleotide	O
is	O
of	O
benefit	O
to	O
only	O
a	O
subset	O
of	O
patients	O
.	O

Exon	O
-skipping	I:C0035687
via	O
synthetic	O
antisense	B:C0079925
oligonucleotides	I:C0079925
represents	O
one	O
of	O
the	O
most	O
promising	O
potential	O
therapies	O
for	O
Duchenne	O
muscular	I:C0013264
dystrophy	I:C0013264
(	O
Duchenne	O
muscular	I:C0013264
dystrophy	I:C0013264
)	O
,	O
yet	O
this	O
approach	O
is	O
highly	O
sequence	O
-	I:C1624609
specific	I:C1624609
and	O
thus	O
each	O
oligonucleotide	O
is	O
of	O
benefit	O
to	O
only	O
a	O
subset	O
of	O
patients	O
.	O

Exon	O
-skipping	I:C0035687
via	O
synthetic	O
antisense	O
oligonucleotides	I:C0079925
represents	O
one	O
of	O
the	O
most	O
promising	O
potential	O
therapies	B:C0087111
for	O
Duchenne	O
muscular	I:C0013264
dystrophy	I:C0013264
(	O
Duchenne	O
muscular	I:C0013264
dystrophy	I:C0013264
)	O
,	O
yet	O
this	O
approach	O
is	O
highly	O
sequence	O
-	I:C1624609
specific	I:C1624609
and	O
thus	O
each	O
oligonucleotide	O
is	O
of	O
benefit	O
to	O
only	O
a	O
subset	O
of	O
patients	O
.	O

Exon	O
-skipping	I:C0035687
via	O
synthetic	O
antisense	O
oligonucleotides	I:C0079925
represents	O
one	O
of	O
the	O
most	O
promising	O
potential	O
therapies	O
for	O
Duchenne	B:C0013264
muscular	I:C0013264
dystrophy	I:C0013264
(	O
Duchenne	O
muscular	I:C0013264
dystrophy	I:C0013264
)	O
,	O
yet	O
this	O
approach	O
is	O
highly	O
sequence	O
-	I:C1624609
specific	I:C1624609
and	O
thus	O
each	O
oligonucleotide	O
is	O
of	O
benefit	O
to	O
only	O
a	O
subset	O
of	O
patients	O
.	O

Exon	O
-skipping	I:C0035687
via	O
synthetic	O
antisense	O
oligonucleotides	I:C0079925
represents	O
one	O
of	O
the	O
most	O
promising	O
potential	O
therapies	O
for	O
Duchenne	O
muscular	I:C0013264
dystrophy	I:C0013264
(	O
Duchenne	B:C0013264
muscular	I:C0013264
dystrophy	I:C0013264
)	O
,	O
yet	O
this	O
approach	O
is	O
highly	O
sequence	O
-	I:C1624609
specific	I:C1624609
and	O
thus	O
each	O
oligonucleotide	O
is	O
of	O
benefit	O
to	O
only	O
a	O
subset	O
of	O
patients	O
.	O

Exon	O
-skipping	I:C0035687
via	O
synthetic	O
antisense	O
oligonucleotides	I:C0079925
represents	O
one	O
of	O
the	O
most	O
promising	O
potential	O
therapies	O
for	O
Duchenne	O
muscular	I:C0013264
dystrophy	I:C0013264
(	O
Duchenne	O
muscular	I:C0013264
dystrophy	I:C0013264
)	O
,	O
yet	O
this	O
approach	O
is	O
highly	O
sequence	B:C1624609
-	I:C1624609
specific	I:C1624609
and	O
thus	O
each	O
oligonucleotide	O
is	O
of	O
benefit	O
to	O
only	O
a	O
subset	O
of	O
patients	O
.	O

Exon	O
-skipping	I:C0035687
via	O
synthetic	O
antisense	O
oligonucleotides	I:C0079925
represents	O
one	O
of	O
the	O
most	O
promising	O
potential	O
therapies	O
for	O
Duchenne	O
muscular	I:C0013264
dystrophy	I:C0013264
(	O
Duchenne	O
muscular	I:C0013264
dystrophy	I:C0013264
)	O
,	O
yet	O
this	O
approach	O
is	O
highly	O
sequence	O
-	I:C1624609
specific	I:C1624609
and	O
thus	O
each	O
oligonucleotide	B:C0028953
is	O
of	O
benefit	O
to	O
only	O
a	O
subset	O
of	O
patients	O
.	O

The	O
discovery	O
that	O
dystrophin	B:C0079259
mRNA	O
is	O
subject	O
to	O
translational	O
suppression	I:C1519619
by	O
the	O
microRNA	O
miR31	O
,	O
and	O
that	O
miR31	O
is	O
elevated	O
in	O
the	O
muscle	O
of	O
Duchenne	O
muscular	I:C0013264
dystrophy	I:C0013264
patients	O
,	O
raises	O
the	O
possibility	O
that	O
the	O
same	O
oligonucleotide	O
chemistries	O
employed	O
for	O
exon	O
skipping	I:C0035687
could	O
be	O
directed	O
toward	O
relieving	O
this	O
translational	O
block	I:C1519619
.	O

The	O
discovery	O
that	O
dystrophin	O
mRNA	B:C0035696
is	O
subject	O
to	O
translational	O
suppression	I:C1519619
by	O
the	O
microRNA	O
miR31	O
,	O
and	O
that	O
miR31	O
is	O
elevated	O
in	O
the	O
muscle	O
of	O
Duchenne	O
muscular	I:C0013264
dystrophy	I:C0013264
patients	O
,	O
raises	O
the	O
possibility	O
that	O
the	O
same	O
oligonucleotide	O
chemistries	O
employed	O
for	O
exon	O
skipping	I:C0035687
could	O
be	O
directed	O
toward	O
relieving	O
this	O
translational	O
block	I:C1519619
.	O

The	O
discovery	O
that	O
dystrophin	O
mRNA	O
is	O
subject	O
to	O
translational	B:C1519619
suppression	I:C1519619
by	O
the	O
microRNA	O
miR31	O
,	O
and	O
that	O
miR31	O
is	O
elevated	O
in	O
the	O
muscle	O
of	O
Duchenne	O
muscular	I:C0013264
dystrophy	I:C0013264
patients	O
,	O
raises	O
the	O
possibility	O
that	O
the	O
same	O
oligonucleotide	O
chemistries	O
employed	O
for	O
exon	O
skipping	I:C0035687
could	O
be	O
directed	O
toward	O
relieving	O
this	O
translational	O
block	I:C1519619
.	O

The	O
discovery	O
that	O
dystrophin	O
mRNA	O
is	O
subject	O
to	O
translational	O
suppression	I:C1519619
by	O
the	O
microRNA	B:C1101610
miR31	O
,	O
and	O
that	O
miR31	O
is	O
elevated	O
in	O
the	O
muscle	O
of	O
Duchenne	O
muscular	I:C0013264
dystrophy	I:C0013264
patients	O
,	O
raises	O
the	O
possibility	O
that	O
the	O
same	O
oligonucleotide	O
chemistries	O
employed	O
for	O
exon	O
skipping	I:C0035687
could	O
be	O
directed	O
toward	O
relieving	O
this	O
translational	O
block	I:C1519619
.	O

The	O
discovery	O
that	O
dystrophin	O
mRNA	O
is	O
subject	O
to	O
translational	O
suppression	I:C1519619
by	O
the	O
microRNA	O
miR31	B:C2607480
,	O
and	O
that	O
miR31	O
is	O
elevated	O
in	O
the	O
muscle	O
of	O
Duchenne	O
muscular	I:C0013264
dystrophy	I:C0013264
patients	O
,	O
raises	O
the	O
possibility	O
that	O
the	O
same	O
oligonucleotide	O
chemistries	O
employed	O
for	O
exon	O
skipping	I:C0035687
could	O
be	O
directed	O
toward	O
relieving	O
this	O
translational	O
block	I:C1519619
.	O

The	O
discovery	O
that	O
dystrophin	O
mRNA	O
is	O
subject	O
to	O
translational	O
suppression	I:C1519619
by	O
the	O
microRNA	O
miR31	O
,	O
and	O
that	O
miR31	B:C2607480
is	O
elevated	O
in	O
the	O
muscle	O
of	O
Duchenne	O
muscular	I:C0013264
dystrophy	I:C0013264
patients	O
,	O
raises	O
the	O
possibility	O
that	O
the	O
same	O
oligonucleotide	O
chemistries	O
employed	O
for	O
exon	O
skipping	I:C0035687
could	O
be	O
directed	O
toward	O
relieving	O
this	O
translational	O
block	I:C1519619
.	O

The	O
discovery	O
that	O
dystrophin	O
mRNA	O
is	O
subject	O
to	O
translational	O
suppression	I:C1519619
by	O
the	O
microRNA	O
miR31	O
,	O
and	O
that	O
miR31	O
is	O
elevated	O
in	O
the	O
muscle	B:C0026845
of	O
Duchenne	O
muscular	I:C0013264
dystrophy	I:C0013264
patients	O
,	O
raises	O
the	O
possibility	O
that	O
the	O
same	O
oligonucleotide	O
chemistries	O
employed	O
for	O
exon	O
skipping	I:C0035687
could	O
be	O
directed	O
toward	O
relieving	O
this	O
translational	O
block	I:C1519619
.	O

The	O
discovery	O
that	O
dystrophin	O
mRNA	O
is	O
subject	O
to	O
translational	O
suppression	I:C1519619
by	O
the	O
microRNA	O
miR31	O
,	O
and	O
that	O
miR31	O
is	O
elevated	O
in	O
the	O
muscle	O
of	O
Duchenne	B:C0013264
muscular	I:C0013264
dystrophy	I:C0013264
patients	O
,	O
raises	O
the	O
possibility	O
that	O
the	O
same	O
oligonucleotide	O
chemistries	O
employed	O
for	O
exon	O
skipping	I:C0035687
could	O
be	O
directed	O
toward	O
relieving	O
this	O
translational	O
block	I:C1519619
.	O

The	O
discovery	O
that	O
dystrophin	O
mRNA	O
is	O
subject	O
to	O
translational	O
suppression	I:C1519619
by	O
the	O
microRNA	O
miR31	O
,	O
and	O
that	O
miR31	O
is	O
elevated	O
in	O
the	O
muscle	O
of	O
Duchenne	O
muscular	I:C0013264
dystrophy	I:C0013264
patients	O
,	O
raises	O
the	O
possibility	O
that	O
the	O
same	O
oligonucleotide	B:C0028953
chemistries	O
employed	O
for	O
exon	O
skipping	I:C0035687
could	O
be	O
directed	O
toward	O
relieving	O
this	O
translational	O
block	I:C1519619
.	O

The	O
discovery	O
that	O
dystrophin	O
mRNA	O
is	O
subject	O
to	O
translational	O
suppression	I:C1519619
by	O
the	O
microRNA	O
miR31	O
,	O
and	O
that	O
miR31	O
is	O
elevated	O
in	O
the	O
muscle	O
of	O
Duchenne	O
muscular	I:C0013264
dystrophy	I:C0013264
patients	O
,	O
raises	O
the	O
possibility	O
that	O
the	O
same	O
oligonucleotide	O
chemistries	O
employed	O
for	O
exon	B:C0035687
skipping	I:C0035687
could	O
be	O
directed	O
toward	O
relieving	O
this	O
translational	O
block	I:C1519619
.	O

The	O
discovery	O
that	O
dystrophin	O
mRNA	O
is	O
subject	O
to	O
translational	O
suppression	I:C1519619
by	O
the	O
microRNA	O
miR31	O
,	O
and	O
that	O
miR31	O
is	O
elevated	O
in	O
the	O
muscle	O
of	O
Duchenne	O
muscular	I:C0013264
dystrophy	I:C0013264
patients	O
,	O
raises	O
the	O
possibility	O
that	O
the	O
same	O
oligonucleotide	O
chemistries	O
employed	O
for	O
exon	O
skipping	I:C0035687
could	O
be	O
directed	O
toward	O
relieving	O
this	O
translational	B:C1519619
block	I:C1519619
.	O

This	O
approach	O
would	O
act	O
synergistically	O
with	O
exon	B:C0035687
skipping	I:C0035687
where	O
possible	O
,	O
but	O
by	O
targeting	O
the	O
3'UTR	O
it	O
would	O
further	O
be	O
of	O
benefit	O
to	O
the	O
many	O
Duchenne	O
muscular	I:C0013264
dystrophy	I:C0013264
patients	O
who	O
express	O
low	O
levels	O
of	O
in	O
-	I:C0080089
frame	I:C0080089
transcript	O
.	O

This	O
approach	O
would	O
act	O
synergistically	O
with	O
exon	O
skipping	I:C0035687
where	O
possible	O
,	O
but	O
by	O
targeting	O
the	O
3'UTR	B:C0600600
it	O
would	O
further	O
be	O
of	O
benefit	O
to	O
the	O
many	O
Duchenne	O
muscular	I:C0013264
dystrophy	I:C0013264
patients	O
who	O
express	O
low	O
levels	O
of	O
in	O
-	I:C0080089
frame	I:C0080089
transcript	O
.	O

This	O
approach	O
would	O
act	O
synergistically	O
with	O
exon	O
skipping	I:C0035687
where	O
possible	O
,	O
but	O
by	O
targeting	O
the	O
3'UTR	O
it	O
would	O
further	O
be	O
of	O
benefit	O
to	O
the	O
many	O
Duchenne	B:C0013264
muscular	I:C0013264
dystrophy	I:C0013264
patients	O
who	O
express	O
low	O
levels	O
of	O
in	O
-	I:C0080089
frame	I:C0080089
transcript	O
.	O

This	O
approach	O
would	O
act	O
synergistically	O
with	O
exon	O
skipping	I:C0035687
where	O
possible	O
,	O
but	O
by	O
targeting	O
the	O
3'UTR	O
it	O
would	O
further	O
be	O
of	O
benefit	O
to	O
the	O
many	O
Duchenne	O
muscular	I:C0013264
dystrophy	I:C0013264
patients	O
who	O
express	O
low	O
levels	O
of	O
in	B:C0080089
-	I:C0080089
frame	I:C0080089
transcript	O
.	O

This	O
approach	O
would	O
act	O
synergistically	O
with	O
exon	O
skipping	I:C0035687
where	O
possible	O
,	O
but	O
by	O
targeting	O
the	O
3'UTR	O
it	O
would	O
further	O
be	O
of	O
benefit	O
to	O
the	O
many	O
Duchenne	O
muscular	I:C0013264
dystrophy	I:C0013264
patients	O
who	O
express	O
low	O
levels	O
of	O
in	O
-	I:C0080089
frame	I:C0080089
transcript	B:C1519595
.	O

We	O
here	O
present	O
investigations	B:C1261322
into	O
the	O
feasibility	O
of	O
combining	O
exon	O
skipping	I:C0035687
with	O
several	O
different	O
strategies	O
for	O
miR31	O
-	O
modulation	O
,	O
using	O
both	O
in	O
vitro	I:C3850137
models	O
and	O
the	O
mdx	O
mouse	I:C0206535
(	O
the	O
classical	O
animal	O
model	I:C0599779
of	O
Duchenne	O
muscular	I:C0013264
dystrophy	I:C0013264
)	O
,	O
and	O
monitoring	O
effects	O
on	O
dystrophin	O
at	O
the	O
transcriptional	O
and	O
translational	O
level	O
.	O

We	O
here	O
present	O
investigations	O
into	O
the	O
feasibility	O
of	O
combining	O
exon	B:C0035687
skipping	I:C0035687
with	O
several	O
different	O
strategies	O
for	O
miR31	O
-	O
modulation	O
,	O
using	O
both	O
in	O
vitro	I:C3850137
models	O
and	O
the	O
mdx	O
mouse	I:C0206535
(	O
the	O
classical	O
animal	O
model	I:C0599779
of	O
Duchenne	O
muscular	I:C0013264
dystrophy	I:C0013264
)	O
,	O
and	O
monitoring	O
effects	O
on	O
dystrophin	O
at	O
the	O
transcriptional	O
and	O
translational	O
level	O
.	O

We	O
here	O
present	O
investigations	O
into	O
the	O
feasibility	O
of	O
combining	O
exon	O
skipping	I:C0035687
with	O
several	O
different	O
strategies	O
for	O
miR31	B:C2607480
-	O
modulation	O
,	O
using	O
both	O
in	O
vitro	I:C3850137
models	O
and	O
the	O
mdx	O
mouse	I:C0206535
(	O
the	O
classical	O
animal	O
model	I:C0599779
of	O
Duchenne	O
muscular	I:C0013264
dystrophy	I:C0013264
)	O
,	O
and	O
monitoring	O
effects	O
on	O
dystrophin	O
at	O
the	O
transcriptional	O
and	O
translational	O
level	O
.	O

We	O
here	O
present	O
investigations	O
into	O
the	O
feasibility	O
of	O
combining	O
exon	O
skipping	I:C0035687
with	O
several	O
different	O
strategies	O
for	O
miR31	O
-	O
modulation	O
,	O
using	O
both	O
in	B:C3850137
vitro	I:C3850137
models	O
and	O
the	O
mdx	O
mouse	I:C0206535
(	O
the	O
classical	O
animal	O
model	I:C0599779
of	O
Duchenne	O
muscular	I:C0013264
dystrophy	I:C0013264
)	O
,	O
and	O
monitoring	O
effects	O
on	O
dystrophin	O
at	O
the	O
transcriptional	O
and	O
translational	O
level	O
.	O

We	O
here	O
present	O
investigations	O
into	O
the	O
feasibility	O
of	O
combining	O
exon	O
skipping	I:C0035687
with	O
several	O
different	O
strategies	O
for	O
miR31	O
-	O
modulation	O
,	O
using	O
both	O
in	O
vitro	I:C3850137
models	O
and	O
the	O
mdx	B:C0206535
mouse	I:C0206535
(	O
the	O
classical	O
animal	O
model	I:C0599779
of	O
Duchenne	O
muscular	I:C0013264
dystrophy	I:C0013264
)	O
,	O
and	O
monitoring	O
effects	O
on	O
dystrophin	O
at	O
the	O
transcriptional	O
and	O
translational	O
level	O
.	O

We	O
here	O
present	O
investigations	O
into	O
the	O
feasibility	O
of	O
combining	O
exon	O
skipping	I:C0035687
with	O
several	O
different	O
strategies	O
for	O
miR31	O
-	O
modulation	O
,	O
using	O
both	O
in	O
vitro	I:C3850137
models	O
and	O
the	O
mdx	O
mouse	I:C0206535
(	O
the	O
classical	O
animal	B:C0599779
model	I:C0599779
of	O
Duchenne	O
muscular	I:C0013264
dystrophy	I:C0013264
)	O
,	O
and	O
monitoring	O
effects	O
on	O
dystrophin	O
at	O
the	O
transcriptional	O
and	O
translational	O
level	O
.	O

We	O
here	O
present	O
investigations	O
into	O
the	O
feasibility	O
of	O
combining	O
exon	O
skipping	I:C0035687
with	O
several	O
different	O
strategies	O
for	O
miR31	O
-	O
modulation	O
,	O
using	O
both	O
in	O
vitro	I:C3850137
models	O
and	O
the	O
mdx	O
mouse	I:C0206535
(	O
the	O
classical	O
animal	O
model	I:C0599779
of	O
Duchenne	B:C0013264
muscular	I:C0013264
dystrophy	I:C0013264
)	O
,	O
and	O
monitoring	O
effects	O
on	O
dystrophin	O
at	O
the	O
transcriptional	O
and	O
translational	O
level	O
.	O

We	O
here	O
present	O
investigations	O
into	O
the	O
feasibility	O
of	O
combining	O
exon	O
skipping	I:C0035687
with	O
several	O
different	O
strategies	O
for	O
miR31	O
-	O
modulation	O
,	O
using	O
both	O
in	O
vitro	I:C3850137
models	O
and	O
the	O
mdx	O
mouse	I:C0206535
(	O
the	O
classical	O
animal	O
model	I:C0599779
of	O
Duchenne	O
muscular	I:C0013264
dystrophy	I:C0013264
)	O
,	O
and	O
monitoring	B:C1283169
effects	O
on	O
dystrophin	O
at	O
the	O
transcriptional	O
and	O
translational	O
level	O
.	O

We	O
here	O
present	O
investigations	O
into	O
the	O
feasibility	O
of	O
combining	O
exon	O
skipping	I:C0035687
with	O
several	O
different	O
strategies	O
for	O
miR31	O
-	O
modulation	O
,	O
using	O
both	O
in	O
vitro	I:C3850137
models	O
and	O
the	O
mdx	O
mouse	I:C0206535
(	O
the	O
classical	O
animal	O
model	I:C0599779
of	O
Duchenne	O
muscular	I:C0013264
dystrophy	I:C0013264
)	O
,	O
and	O
monitoring	O
effects	O
on	O
dystrophin	B:C0079259
at	O
the	O
transcriptional	O
and	O
translational	O
level	O
.	O

We	O
here	O
present	O
investigations	O
into	O
the	O
feasibility	O
of	O
combining	O
exon	O
skipping	I:C0035687
with	O
several	O
different	O
strategies	O
for	O
miR31	O
-	O
modulation	O
,	O
using	O
both	O
in	O
vitro	I:C3850137
models	O
and	O
the	O
mdx	O
mouse	I:C0206535
(	O
the	O
classical	O
animal	O
model	I:C0599779
of	O
Duchenne	O
muscular	I:C0013264
dystrophy	I:C0013264
)	O
,	O
and	O
monitoring	O
effects	O
on	O
dystrophin	O
at	O
the	O
transcriptional	B:C0040649
and	O
translational	O
level	O
.	O

We	O
here	O
present	O
investigations	O
into	O
the	O
feasibility	O
of	O
combining	O
exon	O
skipping	I:C0035687
with	O
several	O
different	O
strategies	O
for	O
miR31	O
-	O
modulation	O
,	O
using	O
both	O
in	O
vitro	I:C3850137
models	O
and	O
the	O
mdx	O
mouse	I:C0206535
(	O
the	O
classical	O
animal	O
model	I:C0599779
of	O
Duchenne	O
muscular	I:C0013264
dystrophy	I:C0013264
)	O
,	O
and	O
monitoring	O
effects	O
on	O
dystrophin	O
at	O
the	O
transcriptional	O
and	O
translational	B:C1519614
level	O
.	O

We	O
show	O
that	O
despite	O
promising	O
results	O
from	O
our	O
cell	B:C0007585
culture	I:C0007585
model	O
,	O
our	O
in	O
vivo	I:C1515655
data	O
failed	O
to	O
demonstrate	O
similarly	O
reproducible	O
enhancement	O
of	O
dystrophin	O
translation	O
,	O
suggesting	O
that	O
miR31	O
-	O
modulation	O
may	O
not	O
be	O
practical	O
under	O
current	O
oligonucleotide	O
approaches	O
.	O

We	O
show	O
that	O
despite	O
promising	O
results	O
from	O
our	O
cell	O
culture	I:C0007585
model	O
,	O
our	O
in	B:C1515655
vivo	I:C1515655
data	O
failed	O
to	O
demonstrate	O
similarly	O
reproducible	O
enhancement	O
of	O
dystrophin	O
translation	O
,	O
suggesting	O
that	O
miR31	O
-	O
modulation	O
may	O
not	O
be	O
practical	O
under	O
current	O
oligonucleotide	O
approaches	O
.	O

We	O
show	O
that	O
despite	O
promising	O
results	O
from	O
our	O
cell	O
culture	I:C0007585
model	O
,	O
our	O
in	O
vivo	I:C1515655
data	O
failed	O
to	O
demonstrate	O
similarly	O
reproducible	O
enhancement	O
of	O
dystrophin	B:C0079259
translation	O
,	O
suggesting	O
that	O
miR31	O
-	O
modulation	O
may	O
not	O
be	O
practical	O
under	O
current	O
oligonucleotide	O
approaches	O
.	O

We	O
show	O
that	O
despite	O
promising	O
results	O
from	O
our	O
cell	O
culture	I:C0007585
model	O
,	O
our	O
in	O
vivo	I:C1515655
data	O
failed	O
to	O
demonstrate	O
similarly	O
reproducible	O
enhancement	O
of	O
dystrophin	O
translation	B:C1519614
,	O
suggesting	O
that	O
miR31	O
-	O
modulation	O
may	O
not	O
be	O
practical	O
under	O
current	O
oligonucleotide	O
approaches	O
.	O

We	O
show	O
that	O
despite	O
promising	O
results	O
from	O
our	O
cell	O
culture	I:C0007585
model	O
,	O
our	O
in	O
vivo	I:C1515655
data	O
failed	O
to	O
demonstrate	O
similarly	O
reproducible	O
enhancement	O
of	O
dystrophin	O
translation	O
,	O
suggesting	O
that	O
miR31	B:C2607480
-	O
modulation	O
may	O
not	O
be	O
practical	O
under	O
current	O
oligonucleotide	O
approaches	O
.	O

We	O
show	O
that	O
despite	O
promising	O
results	O
from	O
our	O
cell	O
culture	I:C0007585
model	O
,	O
our	O
in	O
vivo	I:C1515655
data	O
failed	O
to	O
demonstrate	O
similarly	O
reproducible	O
enhancement	O
of	O
dystrophin	O
translation	O
,	O
suggesting	O
that	O
miR31	O
-	O
modulation	O
may	O
not	O
be	O
practical	O
under	O
current	O
oligonucleotide	B:C0028953
approaches	O
.	O

Possible	O
explanations	O
for	O
this	O
disappointing	O
outcome	O
are	O
discussed	O
,	O
along	O
with	O
suggestions	O
for	O
future	O
investigations	B:C1261322
.	O

